Breakthrough CMV Viremia Outcomes of Letermovir Prophylaxis in Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide
Arthur S. Nguyen(Oregon Health & Science University), Levanto Schachter(Oregon Health & Science University), Andy Chen(Oregon Health & Science University), Eneida R. Nemecek(Oregon Health & Science University), Jessica Leonard(Oregon Health & Science University), Joseph Bubalo(Oregon Health & Science University), Arpita Gandhi(Oregon Health & Science University), Jennifer N. Saultz(Oregon Health & Science University), Rachel J. Cook(Oregon Health & Science University), Yazan Migdady(University of Florida), Richard T. Maziarz(Oregon Health & Science University), Brandon Hayes‐Lattin(Oregon Health & Science University)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577